Associated Papers
Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer.
Xu X et al.
Cancer Research, 2025
Gastric cancer: new genetic developments.
Lynch HT et al.
Journal of Surgical Oncology, 2005
Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
Fuchs M et al.
Journal of Cellular Physiology, 2005
Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors.
Laux H et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2004
Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein.
Fuchs M et al.
Cell Motility and the Cytoskeleton, 2004
Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
Fricke E et al.
Oncology, 2004
Genetic screening for hereditary diffuse gastric cancer.
Oliveira C et al.
Expert Review of Molecular Diagnostics, 2003
Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences.
Handschuh G et al.
Journal of Molecular Biology, 2001
Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate.
Luber B et al.
Cell Adhesion and Communication, 2000
Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas.
Berx G et al.
Cell Adhesion and Communication, 1998
Select a paper to view details